Home/Filings/4/0001839066-25-000025
4//SEC Filing

Reynoso Jamie L. 4

Accession 0001839066-25-000025

CIK 0001801170other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 4:46 PM ET

Size

5.5 KB

Accession

0001839066-25-000025

Insider Transaction Report

Form 4
Period: 2025-11-04
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
  • Sale

    Class A Common Stock

    2025-11-04$3.58/sh30,385$108,7782,793,411 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.49 to $3.67, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

CLOVER HEALTH INVESTMENTS, CORP. /DE

CIK 0001801170

Entity typeother

Related Parties

1
  • filerCIK 0001839066

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:46 PM ET
Size
5.5 KB